{"id":3794,"date":"2020-04-20T12:53:24","date_gmt":"2020-04-20T10:53:24","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/"},"modified":"2020-06-26T14:15:57","modified_gmt":"2020-06-26T12:15:57","slug":"nanexa-lamnar-in-tva-nya-patentansokningar","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/","title":{"rendered":"Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<p><span><span>Nanexa f\u00f6rst\u00e4rker sin patentportf\u00f6lj med ytterligare tv\u00e5 patentans\u00f6kningar. Ans\u00f6kningarna l\u00e4mnades in till det brittiska patentverket (UK Patent Office) den 17 april 2020. Inom prioritets\u00e5ret finns m\u00f6jlighet att f\u00f6lja upp de brittiska patentans\u00f6kningarna med internationella ans\u00f6kningar (PCT-ans\u00f6kningar), vilket ocks\u00e5 Nanexa \u00e4mnar g\u00f6ra.<\/span><\/span><\/p>\n<p><span><span>F\u00f6retagets VD David Westberg kommenterar<\/span><\/span><\/p>\n<p><span><span>V\u00e5rt utvecklingsarbete har resulterat i tv\u00e5 nya uppfinningar som vi anser \u00e4r patenterbara. Det \u00e4r gl\u00e4djande att v\u00e5rt arbete resulterar i nya uppfinningar och de tv\u00e5 patentans\u00f6kningarna som nu inl\u00e4mnats st\u00e4rker Nanexas redan starka patentportf\u00f6lj.<span>F\u00f6r mer information kontakta:<\/span><\/span><\/span><\/p>\n<p><span><span>David Westberg &#8211; VD, Nanexa AB (publ)\u00a0?<span>T<\/span><span>elefon: 0709 -42 83 03?<\/span><\/span><\/span><\/p>\n<p><span><span>E-post: david.westberg@nanexa.se<\/span><\/span><\/p>\n<p><span><span>www.nanexa.com<\/span><\/span><\/p>\n<p><span><span>Om Nanexa AB (publ)<\/span><\/span><span><span>Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar p\u00e5 utvecklingen av<\/span><\/span><span><span>PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor<\/span><\/span><span><span>potential inom ett flertal substanstyper och indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae<\/span><\/span><span><span>utvecklar Nanexa egna projekt och har samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland<\/span><\/span><span><span>AstraZeneca.<\/span><\/span><\/p>\n<\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<p><span><strong><\/strong><\/span><\/p>\n<div class=\"mfn-footer mfn-attachment\">\n<p><strong>Bifogade filer<\/strong><\/p>\n<hr\/>\n<p><a href=\"https:\/\/mb.cision.com\/Main\/12591\/3092374\/1232396.pdf\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">Release<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nanexa f\u00f6rst\u00e4rker sin patentportf\u00f6lj med ytterligare tv\u00e5 patentans\u00f6kningar. Ans\u00f6kningarna l\u00e4mnades in till det brittiska patentverket (UK Patent Office) den 17 april 2020. Inom prioritets\u00e5ret finns m\u00f6jlighet att f\u00f6lja upp de brittiska patentans\u00f6kningarna med internationella ans\u00f6kningar (PCT-ans\u00f6kningar),<\/p>\n<p><a class=\"read-more\" href=\"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/\">L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3794","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa f\u00f6rst\u00e4rker sin patentportf\u00f6lj med ytterligare tv\u00e5 patentans\u00f6kningar. Ans\u00f6kningarna l\u00e4mnades in till det brittiska patentverket (UK Patent Office) den 17 april 2020. Inom prioritets\u00e5ret finns m\u00f6jlighet att f\u00f6lja upp de brittiska patentans\u00f6kningarna med internationella ans\u00f6kningar (PCT-ans\u00f6kningar),L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta property=\"article:modified_time\" content=\"2020-06-26T12:15:57+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/\",\"name\":\"Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2020-04-20T10:53:24+00:00\",\"dateModified\":\"2020-06-26T12:15:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-lamnar-in-tva-nya-patentansokningar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","og_description":"Nanexa f\u00f6rst\u00e4rker sin patentportf\u00f6lj med ytterligare tv\u00e5 patentans\u00f6kningar. Ans\u00f6kningarna l\u00e4mnades in till det brittiska patentverket (UK Patent Office) den 17 april 2020. Inom prioritets\u00e5ret finns m\u00f6jlighet att f\u00f6lja upp de brittiska patentans\u00f6kningarna med internationella ans\u00f6kningar (PCT-ans\u00f6kningar),L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/","og_site_name":"Nanexa AB","article_modified_time":"2020-06-26T12:15:57+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/","name":"Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2020-04-20T10:53:24+00:00","dateModified":"2020-06-26T12:15:57+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-lamnar-in-tva-nya-patentansokningar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa l\u00e4mnar in tv\u00e5 nya patentans\u00f6kningar"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}